Skip to main content

and
  1. Article

    Open Access

    The need for evidence-based strategies and tools for onchocerciasis elimination in Africa

    In a recent article we discussed the feasibility of onchocerciasis elimination in Africa by 2025. We expressed concern that elimination may be impeded by failure to build on the lessons learned in the African ...

    Yankum Dadzie, Uche V. Amazigo, Boakye A. Boatin in Infectious Diseases of Poverty (2019)

  2. Article

    Open Access

    Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes

    Onchocerciasis is found predominantly in Africa where large scale vector control started in 1974. Registration and donation of ivermectin by Merck & Co in 1987 enabled mass treatment with ivermectin in all end...

    Yankum Dadzie, Uche V. Amazigo, Boakye A. Boatin in Infectious Diseases of Poverty (2018)

  3. Article

    Open Access

    Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination

    In most endemic parts of the world, onchocerciasis (river blindness) control relies, or will soon rely, exclusively on mass treatment with the microfilaricide ivermectin. Worldwide eradication of the parasite ...

    William Soumbey Alley, Gerrit J van Oortmarssen, Boakye A Boatin in BMC Public Health (2001)